Yung TM[au] - Search Results

Year	Number of Results
2000	2
2001	1
2003	1
2004	3
2005	1
2006	4
2007	1
2008	1
2009	2
2010	1
2011	1
2012	1
2013	1
2014	3
2015	3
2016	4
2017	2
2020	1
2021	1
2022	0

1

IRX3/5 regulate mitotic chromatid segregation and limb bud shape.

Tao H, Lambert JP, Yung TM, Zhu M, Hahn NA, Li D, Lau K, Sturgeon K, Puviindran V, Zhang X, Gong W, Chen XX, Anderson G, Garry DJ, Henkelman RM, Sun Y, Iulianella A, Kawakami Y, Gingras AC, Hui CC, Hopyan S. Tao H, et al. Among authors: yung tm. Development. 2020 Oct 5;147(19):dev180042. doi: 10.1242/dev.180042. Development. 2020. PMID: 32907847 Free PMC article.

2

Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.

Pepin A, Pernia M, Danner MT, Ayoob M, Yung TM, Lei S, Collins BT, Simeng S, Aghdam N, Collins SP. Pepin A, et al. Among authors: yung tm. Cureus. 2021 Mar 9;13(3):e13780. doi: 10.7759/cureus.13780. Cureus. 2021. PMID: 33842156 Free PMC article.

3

The mechanisms of PML-nuclear body formation.

Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. Shen TH, et al. Among authors: yung tm. Mol Cell. 2006 Nov 3;24(3):331-9. doi: 10.1016/j.molcel.2006.09.013. Mol Cell. 2006. PMID: 17081985 Free PMC article.

4

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer.

Janowski EM, Kole TP, Chen LN, Kim JS, Yung TM, Collins BT, Suy S, Lynch JH, Dritschilo A, Collins SP. Janowski EM, et al. Among authors: yung tm. Front Oncol. 2015 Jul 3;5:151. doi: 10.3389/fonc.2015.00151. eCollection 2015. Front Oncol. 2015. PMID: 26191507 Free PMC article.

5

The Mechanisms of PML-Nuclear Body Formation.

Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. Shen TH, et al. Among authors: yung tm. Mol Cell. 2006 Dec 8;24(5):805. doi: 10.1016/j.molcel.2006.11.010. Epub 2006 Dec 7. Mol Cell. 2006. PMID: 29654784 Free article. No abstract available.

6

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.

Arscott WT, Chen LN, Wilson N, Bhagat A, Kim JS, Moures RA, Yung TM, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP. Arscott WT, et al. Among authors: yung tm. Radiat Oncol. 2014 Jul 24;9:163. doi: 10.1186/1748-717X-9-163. Radiat Oncol. 2014. PMID: 25056726 Free PMC article.

7

Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.

Scaglioni PP, Rabellino A, Yung TM, Bernardi R, Choi S, Konstantinidou G, Nardella C, Cheng K, Pandolfi PP. Scaglioni PP, et al. Among authors: yung tm. EMBO Mol Med. 2012 Jul;4(7):594-602. doi: 10.1002/emmm.201200233. Epub 2012 Mar 21. EMBO Mol Med. 2012. PMID: 22359342 Free PMC article.

8

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.

Paydar I, Cyr RA, Yung TM, Lei S, Collins BT, Chen LN, Suy S, Dritschilo A, Lynch JH, Collins SP. Paydar I, et al. Among authors: yung tm. Front Oncol. 2016 Jul 20;6:167. doi: 10.3389/fonc.2016.00167. eCollection 2016. Front Oncol. 2016. PMID: 27489794 Free PMC article.

9

The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.

Koneru H, Cyr R, Feng LR, Bae E, Danner MT, Ayoob M, Yung TM, Lei S, Collins BT, Saligan L, Simeng S, Kumar D, Collins SP. Koneru H, et al. Among authors: yung tm. Cureus. 2016 Jul 5;8(7):e669. doi: 10.7759/cureus.669. Cureus. 2016. PMID: 27551649 Free PMC article.

10

Cellular dynamics of the negative transcription elongation factor NELF.

Yung TM, Narita T, Komori T, Yamaguchi Y, Handa H. Yung TM, et al. Exp Cell Res. 2009 Jun 10;315(10):1693-705. doi: 10.1016/j.yexcr.2009.02.013. Epub 2009 Feb 23. Exp Cell Res. 2009. PMID: 19245807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results